title: [Evaluation and treatment of interstitial lung disease in Argentine].
abstract: To determine the availability and usual management of interstitial lung diseases (ILD) in our country, the Section of Interstitial Lung Diseases of the Argentine Association for Respiratory Medicine (AAMR) made a survey about diagnostic methodology and treatment of ILD. A total of 115 answers were obtained (38.5%), 43% of them among physicians living in the provinces. Availability of diffusing capacity of the lung for carbon monoxide test (DLCO) is limited: 25.4% never have access to it and 35.6% can seldom use it. Availability to thoracic CT scan is wider: 85% may use if often (32.4%) or always (52.6%). Bronchoscopy is commonly available in 87.7% of the physicians either often (21.9%) or always (65.8%). However, only 20.2% perform BAL and 13.1% transbronchial biopsy in every patient. Only 16.6% perform open lung biopsy or thoracoscopic biopsy in all or most of their patients. Sixty eight percent of physicians who always have availability of DLCO perform it in every patient but only 7.1% of those who seldom have access to DLCO do so (p = 0.0003). Availability of bronchoscopy does not have any influence on the decision of performing BAL or transbronchial biopsy. Frequency of use of surgical biopsy or treatment with immunosuppressive drugs was not influenced by any variable. We conclude that there is a current trend to underuse diagnostic resources for ILD in Argentina. Limitations in availability are relevant regarding DLCO. An effort from the health authorities to centralize the management of patients with ILD would allow to study and treat them according to international recommendations.
authors: Sección Patología Intersticial y Difusa de la Asociación Argentina de Medicina Respiratoria, Buenos Aires, Argentina. camosca@intramed.nect.ar
authors: C
authors: C
authors: Mosca
authors: S
authors: S
authors: Quadrelli
authors: L
authors: L
authors: Castro Zorrilla
authors: J
authors: J
authors: Castagnino
mesh_terms: D001118:Argentina; D016001:Confidence Intervals; D006306:Health Surveys; D006801:Humans; D016015:Logistic Models; D017563:Lung Diseases, Interstitial / Q000175:diagnosis* / Q000188:drug therapy; D010043:Outcome and Process Assessment, Health Care / Q000592:standards*; D018709:Statistics, Nonparametric; D011795:Surveys and Questionnaires